FDA Approves Suflave (polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride)…

View More FDA Approves Suflave

FDA Approves Abilify Asimtufii (aripiprazole) for the Treatment of Schizophrenia or Maintenance Monotherapy Treatment of…

View More FDA Approves Abilify Asimtufii

At a health-screening event in Sarasota, Florida, people gathered in a parking lot and waited…

View More High Inflation and Housing Costs Force Many Americans to Delay Needed Care

For years, the FDA has defended its efforts to intercept prescription drugs coming from abroad…

View More Despite Pharma Claims, Illicit Drug Shipments to US Aren’t Full of Opioids. It’s Generic Viagra.

Takhzyro is the First and Only Prophylaxis Treatment Approved in the U.S. for Children 2…

View More U.S. FDA Approves Takeda’s Takhzyro (lanadelumab-flyo) to Prevent Hereditary Angioedema (HAE) Attacks in Children 2 Years of Age and Older

ROP is a leading cause of childhood blindness worldwide Eylea now approved to treat five…

View More Eylea (aflibercept) Injection Approved as the First Pharmacologic Treatment for Preterm Infants with Retinopathy of Prematurity (ROP) by the FDA

With more than 200 Americans still dying of drug overdoses each day, states are beginning…

View More Schools, Sheriffs, and Syringes: State Plans Vary for Spending $26B in Opioid Settlement Funds

West Virginia will use the U.S. Postal Service and an online account this summer to…

View More Who Doesn’t Text in 2022? Most State Medicaid Programs

LILBURN, Ga. — Matthew Southern, 35, who has intellectual and developmental disabilities, is able to…

View More Desperate for Cash: Programs for People With Disabilities Still Not Seeing Federal Funds